Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis

References

• Alemdaroğlu, C., Degim, Z., Celebi, N., şengezer, M., Alömeroglu, M., Nacar, A. (2008). Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing. J Biomed Mater Res A 85:271–283.
   PubMed Web of Science ®Google Scholar
• Barbieri, C.M., Pilch, D.S. (2006). Complete thermodynamic characterization of the multiple protonation equilibria of the aminiglycoside antibiotic: a calorimetric and natural abundance 15 N NMR study. Biophys J 90:1338–1349.
   PubMed Web of Science ®Google Scholar
• Berman, J.D. (1997). Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684–703.
   PubMed Web of Science ®Google Scholar
• Bouwstra, J.A., Honeywell-Nguyen, P.L. (2002). Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 54(Suppl 1):S41–S55.
   Google Scholar
• Chiang, B., Essick, E., Ehringer, W., Murphree, S., Hauck, M.A., Li, M., et al. (2007). Enhancing skin wound healing by direct delivery of intracellular adenosine triphosphate. Am J Surg 193:213–218.
   PubMed Web of Science ®Google Scholar
• Coderch, L., Fonollosa, J., De, Pera M, Estelrich, J., De, La Maza A, Parra, J.L. (2000). Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption. J Contr Rel 68:85–95.
   PubMed Web of Science ®Google Scholar
• Croft, S.L., Coombs, G.H. (2003). Leishmaniasis: current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 19:502–508.
   PubMed Web of Science ®Google Scholar
• Croft, S.L., Seifert, K., Yardley, V. (2006). Current scenario of drug development for leishmaniasis. Ind J Med Res 123:399–410.
   PubMed Web of Science ®Google Scholar
• Desjeux, P. (2004). Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305–318.
   PubMed Web of Science ®Google Scholar
• Diembeck, W., Beck, H., Benech-Kieffer, F., Courtellemont, P., Dupuis, J., Lovell, W., et al. (1999). Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 37:191–205.
   PubMed Web of Science ®Google Scholar
• Dubey, V., Mishra, D., Asthana, A., Jain, N.K. (2006). Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials 27:3491–3496.
   PubMed Web of Science ®Google Scholar
• El-On, J., Halevy, S., Grunwald, M.H., Weinrauch, L. (1992). Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 27:227–231.
   PubMed Web of Science ®Google Scholar
• El-On, J., Jacobs, G.P., Witztum, E., Greenblatt, C.L. (1984). Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals. Antimicrob Agents Chemother 26:745–751.
   PubMed Web of Science ®Google Scholar
• Ferreira, L.S., Souza, R.C.C., Tavares, C.A.P., Nunan, E.A., Fernandes, A.P., Ferreira, LAM. (2002). Development of hydrophilic formulations containing paromomycin for topical treatment of the cutaneous leishmaniasis. Rev Soc Bras Med Trop 35:S113–S117.
   Google Scholar
• Ferreira, L.S., Ramaldes, G.A., Nunan, E.A., Ferreira, LAM. (2004). In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis. Drug Dev Ind Pharm 30:289–296.
   PubMed Web of Science ®Google Scholar
• Garnier, T., Croft, S.L. (2002). Topical treatment for cutaneous leishmaniasis. Curr Opin Invest Drugs 3:538–544.
   PubMedGoogle Scholar
• Garnier, T., Mäntylä,; A., Järvinen, T., Lawrence, J., Brown, M., Croft, S. (2007). In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J Antimicrob Chemother 60:802–810.
   PubMed Web of Science ®Google Scholar
• Grevelink, S.A., Lerner, E.A. (1996). Leishmaniasis. J Am Acad Dermatol 34:257–272.
   PubMed Web of Science ®Google Scholar
• Honzak, L., šentjurc, M., Swartz, H.M. (2000). In vivo EPR of topical delivery of a hydrophilic substance encapsulated in multilamellar liposomes applied to the skin of hairless and normal mice. J Contr Rel 66:221–228.
   PubMed Web of Science ®Google Scholar
• Jacobi, U., Kaiser, M., Toll, R., Mangelsdorf, S., Audring, H., Otberg, N., et al. (2007). Porcine ear skin: an in vitro model for human skin. Skin Res Technol 13:19–24.
   PubMed Web of Science ®Google Scholar
• Kim, M.-.K., Chung, S.-.J., Lee, M.-.H., Cho, A.-.R., Shin, C-K. (1997). Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J Contr Rel 46:243–251.
   Web of Science ®Google Scholar
• Langer, S., Botteck, N.M., Bosse, B., Reimer, K., Vogt, P.M., Steinau, H.U., et al. (2006). Effect of polyvinylpyrrolidone-iodine liposomal hydrogel on wound microcirculation in SKH1-hr hairless mice. Eur Surg Res 38:27–34.
   PubMed Web of Science ®Google Scholar
• Lee, J.P., Jalili, R.B., Tredget, E.E., Demare, J.R., Ghahary, A. (2005). Antifibrogenic effects of liposome-encapsulated IFN-2b cream on skin wounds in a fibrotic rabbit ear model. J Interf Cytok Res 25:627–631.
   PubMed Web of Science ®Google Scholar
• Lopes, L.B., Lopes, J.L., Oliveira, D.C., Thomazini, J.A., Garcia, M.T., Fantini, M.C., et al. (2006). Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. Eur J Pharm Biopharm 63:146–155.
   PubMed Web of Science ®Google Scholar
• Moon, K.C., Wester, R.C., Maibach, H.I. (1990). Diseased skin models in the hairless Guinea pig: in vivo percutaneous absorption. Dermatologica 180:8–12.
   PubMedGoogle Scholar
• Neal, R.A., Allen, S., McCoy, N., Olliaro, P., Croft, S.L. (1995). The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother 35:577–584.
   PubMed Web of Science ®Google Scholar
• Neal, R.A., Murphy, A.G., Olliaro, P., Croft, S.L. (1994). Aminosidine ointments for the treatment experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 88:223–225.
   PubMed Web of Science ®Google Scholar
• Neva, F.A., Ponce, C., Ponce, E., Kreutzer, R., Modabber, F., Olliaro, P. (1997). Nonulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Trans R Soc Trop Med Hyg 91:473–475.
   PubMed Web of Science ®Google Scholar
• Roy, S.D., Hou, S.-.Y., Witham, S.L., Flynn, G.L. (1994). Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver and hairless mouse skin. J Pharm Sci 83:1723–1728.
   PubMed Web of Science ®Google Scholar
• Sekkat, N., Kalia, Y.N., Guy, R.H. (2004). Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss. J Pharm Sci 93:2936–2940.
   PubMed Web of Science ®Google Scholar
• Simon, G.A., Maibach, H.I. (2000). The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations: an overview. Skin Pharmacol Appl Skin Physiol 13:229–234.
   PubMedGoogle Scholar
• Soto, J., Fuya, P., Herrera, R., Berman, J.D. (1998). Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment or American cutaneous leishmaniasis: controlled study. Clin Infect Dis 26:56–58.
   PubMed Web of Science ®Google Scholar
• Soto, J., Toledo, J., Gutierrez, P., Arboleda, M., Nicholls, R., Padilla, J., et al. (2002). Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. Am J Trop Med Hyg 66:147–151.
   PubMed Web of Science ®Google Scholar
• Sung, K.C., Fang, J.Y., Wang, J.J., Hu, O.Y. (2003). Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci 18:63–70.
   PubMed Web of Science ®Google Scholar
• Verma, D.D., Verma, S., Blume, G., Fahr, A. (2003). Liposomes increase skin penetration of entrapped and Non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 55:171–277.
   Google Scholar
• Vorauer-Uhl, K., Fürnschlief, E., Wagner, A., Ferko, B., Katinger, H. (2001). Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation. Eur J Pharm Sci 14:63–67.
   PubMed Web of Science ®Google Scholar
• Weigmann, H.-.J., Ulrich, J., Schanzer, S., Jacobi, U., Schaefer, H., Sterry, W., et al. (2005). Comparison of transepidermal water loss and spectroscopic absorbance to quantify changes of the stratum corneum after tape stripping. Skin Pharmacol Physiol 18:180–185.
   PubMed Web of Science ®Google Scholar